CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
The US Department of Health and Human Services has decided to spend nearly $600 million on the development of a bird flu ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.
Nationally, this avian flu sickened at least 66 people in 2024, mostly dairy farmworkers who came in contact with diseased ...
Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of ...
Moderna’s current price is less than $20 below the psychologically significant $50 price level. Traders often focus on these ...
Moderna (NASDAQ:MRNA) shares are on course for a 21% weekly increase as of Wednesday. The leap highlights worries about the possible spread of the H5N1 avian flu followingthe first death connected ...
Moderna led S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S. The biotech company is developing a vaccine for H5N1.